Skip to Main Content
Table 3

Association of genetic polymorphisms and tobacco smoking with the risk of ovarian cancer

GenotypeNever smokedEver smokedPb for interaction
CasesControlsORa95% CICasesControlsORa95% CI
CYP1A1 (MspI         
m1/m1 35 47 1c  19 29 0.8 0.4–1.9  
 Any m2 36 50 0.9 0.5–1.8 32 18 2.6 1.2–6.0 0.03 
CYP1A1 (Ile/Val         
A/A 50 64 1c  40 38 1.4 0.7–2.7  
 Any G 22 33 0.7 0.4–1.5 12 1.8 0.6–5.1 0.37 
CYP1A2           
A/A 45 52 1c  28 15 2.6 1.1–5.9  
 Any C 24 42 0.7 0.4–1.3 19 29 0.9 0.4–1.9 0.15 
CYP1B1          
Leu/Leu 39 63 1c  28 32 1.3 0.6–9.3  
 Any Val 37 34 1.9 0.9–3.7 24 15 3.8 1.6–9.8 0.54 
COMT          
Val/Val 34 45 1c  18 23 1.2 0.5–2.9  
 Any Met 39 52 1.2 0.6–2.2 34 24 2.2 1.0–4.7 0.36 
GenotypeNever smokedEver smokedPb for interaction
CasesControlsORa95% CICasesControlsORa95% CI
CYP1A1 (MspI         
m1/m1 35 47 1c  19 29 0.8 0.4–1.9  
 Any m2 36 50 0.9 0.5–1.8 32 18 2.6 1.2–6.0 0.03 
CYP1A1 (Ile/Val         
A/A 50 64 1c  40 38 1.4 0.7–2.7  
 Any G 22 33 0.7 0.4–1.5 12 1.8 0.6–5.1 0.37 
CYP1A2           
A/A 45 52 1c  28 15 2.6 1.1–5.9  
 Any C 24 42 0.7 0.4–1.3 19 29 0.9 0.4–1.9 0.15 
CYP1B1          
Leu/Leu 39 63 1c  28 32 1.3 0.6–9.3  
 Any Val 37 34 1.9 0.9–3.7 24 15 3.8 1.6–9.8 0.54 
COMT          
Val/Val 34 45 1c  18 23 1.2 0.5–2.9  
 Any Met 39 52 1.2 0.6–2.2 34 24 2.2 1.0–4.7 0.36 
a

Adjusted by multiple unconditional logistic regression for age, ethnicity, education, pregnancy history, oral contraceptive pill use, history of tubal ligation, and regularity of menstrual cycles.

b

Based on the likelihood ratio test comparing models with and without an interaction term.

c

Reference category.

Close Modal

or Create an Account

Close Modal
Close Modal